Glaucoma Clinical Trial
Official title:
To Compare the Intraluminal Stenting and External Ligation of Ahmed Glaucoma Valve (AGV) Regarding Refractory Glaucoma Management and Postoperative Hypotony Prevention.
Objectives: To compare the intraluminal stenting and external ligation of Ahmed Glaucoma
Valve (AGV) regarding refractory glaucoma management and postoperative hypotony prevention.
Patients and Methods: This randomized clinical trial included 30 eyes of 25 patients (age
range: 44-56 y) with refractory glaucoma. This study was conducted during the period from
September 2018 to January 2020. The study included two groups, AGV with intraluminal stenting
group (n=15) and AGV with external ligation group (n=15). Follow up continued to a year post
operation. The primary outcome was Intraocular pressure (IOP) and its association with the
number of postoperative glaucoma medications. IOP ≤ 21 mmHg without medications announced
complete success while IOP ≤ 21 mmHg with medications indicated qualified success. IOP of <6
mmHg defined hypotony.
Key Words: Stenting- ligation- Ahmed valve- Hypotony
Introduction: Refractory glaucoma is a complicated type of glaucoma difficult to be treated.
This type is characterized by high IOP with a high resistance to be reduced by traditional
medical or surgical therapy. Shunt surgery improve trabeculectomy poor long term outcomes in
refractory glaucoma.1 AGV, a shunt device, is used either from the start or after
conventional procedures failure in refractory glaucoma. It helps the aqueous humour flow
direct in the silicone tube.2 AGV is effective in reducing the postoperative hypotony
commonly seen in non valved implants however the presence of persistent hypotony is still a
problem after AGV.3 Persistent hypotony after AGV is caused by over-priming the tube and
excessive manipulation of the valve housing that may damage the valve mechanism, the outflow
of aqueous humour around the silicone tube immediately post-operatorive after the utilization
of a 22 or 23G needle in creation of the sclerostomy and ciliary body function failure
post-surgery in complicated eyes in which AGV is used. 4-5 closure of the tube by ligation or
stenting may be needed when postoperative ocular hypotony occurs. 6 Enough and expected
outflow control may not be induced by ligation of the tube at a focal area. 7 postoperative
ocular hypotony could be managed effectively by Ab interno tube stenting. 8-10 Patients and
Methods: Thirty eyes with refractory glaucoma were included in randomized controlled clinical
trial. Patients aged from 44 to 56 years old. Despite of tolerated medication after previous
trabeculectomy surgery, those patients had high intraocular pressure (IOP). Approval of
institutional research board committee was taken. Two groups were studied; AGV with
intraluminal stenting group (n=15 eyes) and AGV with external ligation group (n=15 eyes).
Follow- up to one year after the surgery was done. The primary outcome was Intraocular
pressure (IOP) and its association with the number of postoperative glaucoma medications. IOP
≤ 21 mmHg without medications announced complete success while IOP ≤ 21 mmHg with medications
indicated qualified success. IOP of <6 mmHg defined hypotony. All patients preoperatively
were subjected to IOP measurement using Goldman applanation tonometer, visual acuity
assessment (VA) using Snellen E chart, visual field analysis (VF) by Humphrey visual field
analyzer, Angle examination by goniolens, optic disc examination by Volk+90 lens, sit lamp
examination for assessment of corneal clarity and any corneal touch with the tube and
anterior chamber depth. All patients had peribulbar anaesthesia. Operative technique: in
group I, incision of superior-temporal conjunctiva was carried out, appropriate cauterization
and approximately at 10 mm posterior to the corneal limbus, the valve body plate was placed.
Forceps was used to insert A 7-0 prolene thread into the tube lumen; the prolene 7-0 thread
was cut with scissors making it along the tube length to remove it when needed. (Figure 2) In
group II, the same as in group I but 8-0 vicryl was used to ligate the tube with the
underlying sclera in addition to usage of two interrupted prolene 7-0 sutures applied 2mm
apart over the tube itself to make partial occlusion and then entered into the anterior
chamber. (Figure 3) Postoperative treatment with combined antibiotic and steroid eye drops
every four hours in the first week followed by 2 weeks gradual tapering. IOP, VA, VF, optic
disc examination by Volk+90 lens, slit lamp examination were the follow-up parameters.
Failure was considered if the patient needed to implant removal, added glaucoma surgery, or
developed phthisis bulbi.
Statistical analysis: Data were statistically analyzed by SPSS version 22(SPSS Inc., Chicago,
IL, USA). Non-paired t test and Mann-Whitney were applied to quantitative variables. Fisher's
exact test was applied to qualitative variables. Correlation was used to assess strength and
direction of association. Less than 0.05 P value was set to be significant.
Data Availability Statement:The data used to support the findings of this study are included
within the article.
Compliance with Ethical Standards Funding Statement: None Conflicts of Interest: The author
declares that there he has no conflict of interest regarding the publication of this paper.
Ethical approval: All procedures performed in studies involving human participants were in
accordance with the ethical standards of the institutional committee and with the 1964
Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent: Informed consent was obtained from all individual participants included in
the study.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06000865 -
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE
|
N/A | |
Recruiting |
NCT06278597 -
Automatic Evaluation of the Anterior Chamber Angle Width by a New Non-contact Optical Device
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03274024 -
The Asia Primary Tube Versus Trab (TVT) Study
|
N/A | |
Completed |
NCT04552964 -
Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma
|
N/A | |
Recruiting |
NCT01957267 -
Functional and Structural Imaging for Glaucoma
|
||
Active, not recruiting |
NCT04624698 -
iStent Inject New Enrollment Post-Approval Study
|
N/A | |
Completed |
NCT04020705 -
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
|
N/A | |
Completed |
NCT03150160 -
Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
|
Phase 4 | |
Not yet recruiting |
NCT05581498 -
Glaucoma Exercise as Medicine Study (GEMS).
|
N/A | |
Recruiting |
NCT02921568 -
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
|
N/A | |
Active, not recruiting |
NCT02901730 -
Clinical Study of LPI With Different Laser Wavelengths
|
N/A | |
Completed |
NCT02955849 -
A Trial of China Laser and Surgery Study Glaucoma in Rural China
|
Early Phase 1 | |
Recruiting |
NCT02554214 -
Pilot Clinical Trial on a New Adjustable Glaucoma Drainage Device
|
N/A | |
Recruiting |
NCT02471105 -
Investigation of IOP and Tolerability of Bimatoprost 0.01% and Tafluprost Unit Dose Preservative Free 15 Microgram/ml
|
Phase 4 | |
Active, not recruiting |
NCT02390284 -
Stop Retinal Ganglion Cell Dysfunction Study
|
Phase 3 | |
Completed |
NCT02390245 -
Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study
|
N/A | |
Completed |
NCT02653963 -
Triamcinolone for Ahmed Glaucoma Valve
|
N/A | |
Completed |
NCT02628223 -
180 Degree vs. 360 Degree Selective Laser Trabeculoplasty as Initial Therapy for Glaucoma
|
N/A | |
Completed |
NCT02520674 -
Glaucoma Screening With Smartphone Ophthalmology
|
N/A |